Researchers from the Molecular Nutrition and Health Lab and collaborators from the James Hutton Institute and Faculty of Pharmacy from Lisbonco published their findings in Scientific Reports (Nature Group).
ISPROF2017 took place in Capuchos, Caparica, Portugal, between the 4th and 7th of September 2017.
MC describes the work that has been going on at iBET and how it impacts in advancing the development of bioprocesses for vaccines and viral vectors for gene therapy
Check out iBET's most Recent News: Collaborations; Research Highlights; New Projects; Awards and much more
This new vaccine is expected to be long lasting and multivalent, protecting against 5 types of Influenza virus. It has also the advantage of being safe as it is devoid of genetic material.
iBET is one of the partners in this EU funded project which aims to develop Innovative Eco-Technologies for Resource Recovery from Wastewater
This is a key instrument in the continued partnership between the Structural Biology for Drug Discovery Unit at iBET in Oeiras and the Molecular Interactions and Biophysics Group at Merck in Darmstadt.